Related Experiment Video
Updated: May 10, 2025

09:49
Isolation of Adipose Derived Regenerative Cells for the Treatment of Erectile Dysfunction Following Radical Prostatectomy
Published on: December 28, 2021
3.2K
A Prospective Randomized Study on Low-Energy Extracorporeal Shock Wave Therapy for Erectile Dysfunction After Radical
Torben Brøchner Pedersen1,2, Caroline Secher1,2, Ali Moumneh1
1Department of Urology, Odense University Hospital, Odense, Denmark.
The Journal of Urology
|April 27, 2025
Summary
Low-energy shockwave therapy (LI-SWT) did not significantly improve erectile function in men post-prostatectomy compared to sham treatment. Erectile function outcomes remained similar between groups at 24 weeks.
Area of Science:
- Urology
- Andrology
- Regenerative Medicine
Background:
- Radical prostatectomy often leads to erectile dysfunction.
- Erectile function recovery is a significant concern for post-prostatectomy patients.
- Low-energy extracorporeal shockwave therapy (LI-SWT) is being explored as a potential treatment.
Purpose of the Study:
- To assess the efficacy of LI-SWT versus sham treatment for improving erectile function after radical prostatectomy.
- To compare outcomes using the Erection Hardness Score (EHS) and International Index of Erectile Function (IIEF).
Main Methods:
- 75 participants were randomized to LI-SWT or sham treatment.
- Erectile function was evaluated at baseline and 4, 12, 24 weeks post-treatment.
- Statistical analysis included zero-inflated negative binomial and nonparametric methods.
Main Results:
- No statistically significant difference in IIEF scores between LI-SWT and sham groups (P=.469).
- Median IIEF scores were 4 in both groups at 24 weeks.
- No significant difference in EHS scores or the proportion of patients achieving sufficient erection hardness (EHS ≥3) at 24 weeks.
Conclusions:
- LI-SWT did not demonstrate statistically significant improvement in erectile function compared to sham treatment in this patient cohort.
- Further research may be needed to explore alternative or adjunctive therapies for post-prostatectomy erectile dysfunction.

